Sensus Healthcare, Inc. SRTS revenue by segment, product and geography
In its fiscal year ending 2025-12-31, Sensus Healthcare, Inc. reported revenue across 4 products and services; the largest, Product, was $19.8M, 71.9% of the filed sum (-45.7% against the prior period in the same filing).
Reported segment mix
figures as filed · share of the filed sum · change vs the prior period in the same filing- Product$19.8M71.9%-45.7% yoy
- Service Revenue$3.46M12.6%+8.1% yoy
- Service$2.54M9.2%+29.6% yoy
- Product Revenue$1.72M6.3%+596.8% yoy
Members sum to the consolidated $27.5M for this period.
- United States$25.4M92.3%-36.9% yoy
- China$2.03M7.4%+40.5% yoy
- Other$90K0.3%-50.5% yoy
Members sum to the consolidated $27.5M for this period.
- Product$1.65M48.7%-75.4% yoy
- Service Revenue$875K25.8%+7.6% yoy
- Service$523K15.4%-16.2% yoy
- Product Revenue$343K10.1%+72.4% yoy
Change is against the same quarter a year earlier, as reported in the same 10-Q.
Source: SEC DERA Financial Statement and Notes data sets. Dimensional XBRL facts on the business-segment, product/service and geographic axes; the engine keeps the accession of every figure. Descriptive and educational, not advice.
About these figures
Companies tag segment, product and geographic revenue as dimensional XBRL facts in their 10-K and 10-Q filings. The SEC publishes those facts in its DERA Financial Statement and Notes data sets; TrendNalysis ingests each monthly file and serves the facts exactly as filed, keyed to the accession of the filing. Shares are of the filed sum. Where a filer tags more than one breakdown on one axis, the sum exceeds consolidated revenue and no shares are computed; where the members do not add up to the consolidated figure, the residual is stated rather than hidden. Missing is never zero.
Descriptive and educational; not investment advice. Methodology and data lineage.